Abbott Laboratories
ABTAbbott Laboratories (ABT) is a global healthcare company that develops, manufactures, and markets a wide range of healthcare products, including pharmaceuticals, diagnostic tools, medical devices, and nutritional products. Founded in 1888, Abbott is known for innovative solutions in medical diagnostics, cardiovascular and neurology devices, and nutrition, serving patients and healthcare providers worldwide.
Dividend History
Investors can expect a dividend payout of $0.63 per share, scheduled to be distributed in 38 days on February 13, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| February 13, 2026 | $0.63 | 2026-01-15 | 2026-01-15 |
| November 17, 2025 | $0.59 | 2025-10-15 | 2025-10-15 |
| August 15, 2025 | $0.59 | 2025-07-15 | 2025-07-15 |
| May 15, 2025 | $0.59 | 2025-04-15 | 2025-04-15 |
| February 14, 2025 | $0.59 | 2025-01-15 | 2025-01-15 |
Dividends Summary
- Abbott Laboratories has issued 89 dividend payments over the past 22 years
- The most recent dividend was paid 50 days ago, on November 17, 2025
- The highest dividend payed out to investors during this period was $0.63 per share
- The average dividend paid during this period was $0.36 per share.
Company News
AbbVie is rated a strong buy for 2026 based on robust financial performance, strong revenue growth guidance through 2029, outperformance of key drugs like Skyrizi and Rinvoq, reasonable valuation metrics, and an exceptional dividend program with 54 consecutive years of raises.
Multiple companies across healthcare, energy, and semiconductors are raising dividends at double-digit rates, signaling confidence in cash flows. Abbott Laboratories increased its dividend by 6.8% marking 54 consecutive years of increases, Nordic American Tankers raised its payout by 30%, and Broadcom announced a 10% dividend increase backed by a...
The transcatheter heart valve replacement market is projected to grow from $6.40 billion in 2025 to $19.98 billion by 2033, with a 15.32% CAGR, driven by rising valvular heart disease prevalence and preference for minimally invasive cardiac procedures.
Abbott Laboratories announced a 6.8% increase in its quarterly dividend to 63 cents per share, marking its 54th consecutive year of dividend growth and maintaining its status as a member of the S&P 500 Dividend Aristocrats Index.
Hims & Hers Health, Inc. (HIMS) has seen a 45.8% stock price increase in the past three months, outperforming the industry and broader market. The company's recent announcements, including the addition of GLP-1 injections to its weight loss portfolio and positive 2024 revenue outlook, have contributed to the stock's upward momentum.
